Kotulak-Chrzaszcz et al. had shown that SMO, Gli1, and Shh could promote progression of cervical cancer, but no drugs targeting SMO, Gli1, and Shh were approved for prevention and therapy of cervical cancer [30]. This evidence concerns the gene SMO and cervical cancer.